The prognostic value of serum inhibin, 17β-estradiol and progesterone in cases of hydatidiform mole

Gynecological Endocrinology

Volumn 18, Issue 2, 2004, Pages 107-113

  Hegab, H M ^a   Schindler, A E ^b,c  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

17 Estradiol; Hydatidiform Mole; Inhibin; Progesterone

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; ESTRADIOL; INHIBIN; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ESTRADIOL BLOOD LEVEL; FEMALE; GESTATIONAL AGE; GRAVITY; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PARITY; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; THERAPEUTIC ABORTION; TROPHOBLASTIC TUMOR;

ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ESTRADIOL; FEMALE; HUMANS; HYDATIDIFORM MOLE; INHIBINS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 1342284360     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590310001652991     Document Type: Article

References (36)

1. Carranza-Lira S, Hernandez F, Sanchez M, et al. Prolactin secretion in molar and normal pregnancy. Int J Gynecol Obstet 1998;60:137-41
2. Tangtrakul S, Srisupandit S, Chailurkit LO, et al. Preevacuation serum CA 125 in complete hydatidiform mole. Gynecol Oncol 1997;64:487-9
3. Yedema KA, Verheijen RH, Kenemans P, et al. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 1993;168:787-92
4. Osathanondh R, Berkowitz RS, de Cholnoky C, et al. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med 1986;31:179-83
5. Ho B. Relationship of prolactin and estradiol to human chorionic gonadotropin following molar gestation. Am J Obstet Gynecol 1983;145:618-20
6. Massart C, Le Pogamp C, Nicol M. Serum and tissue 17 beta hydroxysteroid dehydrogenase and estrogens in hydatidiform mole. J Clin Chem Clin Biochem 1983; 21:77-82
7. Massart C, Le Pogamp C, Nicol M. Plasma hormone concentrations and serum 17 beta-hydroxysteroid dehydrogenase activity in molar pregnancy. Clin Chem 1982;28:1474-7
8. Jiang SW, Lloyd RV, Jin L, et al. Estrogen receptor expression and growth-promoting function in human choriocarcinonia cells. DNA Cell Biol 1997;16: 969-77
9. Miyakawa I, Yagi K, Nakayama M, et al. Plasma levels of human chorionic somatomammotrophin, progesterone, unconjugated oestradiol and oestriol, and alpha-foetoprotein in patients with hydatidiform moles. J Endocrinol 1977;72:371-8
10. Ho PC, Wong LC, Ma HK. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation. Obstet Gynecol 1986;67:99-106
11. Pelkey TJ, Frierson HF Jr, Mills SE, et al. Detection of the alpha subunit of inhibin in trophoblastic neoplasia. Hum Pathol 1999;30:26-31
12. Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 1999;18:144-50
13. Yohkaichiya T, Fukaya T, Hoshiai H, et al. Inhibin: a new circulating marker of hydatidiform mole? Br Med J 1989;289:1684-6
14. Pautier P, Ghione S, Brailly-Tabard S, et al. Are serum inhibin concentrations new markers of placental tumors in the course of chemotherapy? Hum Reprod 2001;16:2434-7
15. Vasilev SA, Schlaerth JB, Ahn C, et al. Serum progesterone monitoring in post-molar surveillance. Gynecol Oncol 1994;54:288-91
16. Rodriguez GC, Hughes CL, Soper JT, et al. Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia. Obstet Gynecol 1994;84:794-7
17. Dawood YM, Teoh ES. Disappearance of serum progesterone after normal delivery and after hydatidiform mole. Obstet Gynecol 1975;45:9-12
18. Webb R, Campbell BK, Garverick HA, et al. Molecular mechanisms regulating follicular recruitment and selection. J Reprod Fertil 1993;54:33-48
19. Frias AE, Li H, Keeny GI, et al. Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma. Cancer 1999;85:465-71
20. Lappöhn RE, Burger HG, Bouma J, et al. Inhibin as a marker for granulosa cell tumor. N Engl J Med 1989;321:790-3
21. Healy DL, Burger HG, Mammers P, et al. Elevated serum level of inhibin concentrations in post-menopausal women with ovarian tumors. N Engl J Med 1993;329:1539-42
22. Jones RL, Salamonsen LA, Findlay JK. Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol Metab 2002;13:144-50
23. Roberts VJ, Barth SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid and late gestation rat embryogenesis. Endocrinology 1994;135:914-23
24. Kommoss F, Schmidt D, Coerdt W, et al. Immunohistochemical expression analysis of inhibin-alpha and -beta subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua. Int J Gynecol Pathol 2001;20:380-5
25. Badonnel Y, Barbe F, Legagneur H, et al. Inhibin as a marker for hydatidiform mole: a comparative study with the determination of intact human chorionic gonadotrophin and its free beta-subunit. Clin Endocrinol 1994;41:155-62
26. McCluggage WG, Ashe P, McBride H, et al. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 1998;32:252-6
27. Minami S, Yamoto M, Nakano R. Immunohistochemical localization of inhibin-activin subunits in hydatidiform mole and invasive mole. Obstet Gynecol 1993;82:414-18
28. WHO Scientific Group on Gestational Trophoblastic Diseases. Gestational Trophoblastic Diseases. Geneva: World Health Organization, 1983:1-81
29. Paulmorrow C. Postmolar trophoblastic disease: diagnosis, management and prognosis. Clin Obstet Gynecol 1984;27:211-20
30. Cunningham FG, MacDonald PC, Gant NF, eds. Diseases and abnormalities of the placenta and membranes. In Williams Obstetrics, 18th edn. Norwalk, CT: Appleton and Lange, 1989:533-59
31. Lurain J, Brewer J, Torok E, et al. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983;145:591
32. Canfield RE, Ross GT. A new reference preparation of human chorionic gonadotropin and its subunits. Bull World Health Organ 1976;54:463-70
33. Florio P, Severi FM, Cobellis L, et al. Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Cancer 2002;94:2618-22
34. Curry SL, Hammond CB, Terqy L, et al. Hydatidiform mole: diagnosis, management and long-term follow up of 347 patients. Obstet Gynaecol 1975;45:1
35. Morrow CP, Klettky OA, Disaia PJ. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol 1977;128:424
36. Kohorn EL. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol 1982;59:78